Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1−M4 muscarinic receptors: Use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes
- 1 June 1995
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 20 (6) , 669-674
- https://doi.org/10.1007/bf01705534
Abstract
The relative affinities of various muscarinic drugs in the antagonist ([3H]N-methyl scopolamine ([3H]NMS)) and agonist ([3H]Oxotremorine-m ([3H]OXO-M)) binding assays using a mixture of tissues containing M1−M4 receptor subtypes have been determined. [3H]NMS bound with high affinity (Kd=25±5.9 pM; n=3) and to a high density (Bmax=11.8±0.025 nmol/g wet weight) of muscarinic receptors. [3H]OXO-M appeared to bind to two binding sites with differing affinities (Kd1=2.5±0.1 nM; Kd2=9.0±4.9 μM; n=4) and to a different population of binding sites (Bmax1=5.0±0.26 nmol/g wet weight; Bmax2=130±60 nmol/g wet weight). Well known antagonists exhibited high affinity for [3H]NMS binding but a lower affinity for [3H]OXO-M binding. The opposite was true for acetylcholine and other known agonists. However, pilocarpine and McN-A-343 had similar affinities for sites labeled by both radioligands. Using the ratios of antagonist-to-agonist binding affinities, it was possible to group compounds into apparently distinct full agonist (ratios of 180–665; e.g. carbachol, muscarine, OXO-M, OXO-S and arecoline), partial agonist (ratios of 14–132; e.g. McN-A-343, pilocarpine, aceclidine, bethanechol, OXA-22 and acetylcholine) and antagonist (ratios of 0.22–1.9; e.g. atropine, NMS, pirenzepine, methoctramine, 4-DAMP and p-fluorohexahydrosialo-difenidol) classes. These data suggest that the NMS/OXO-M affinity ratios using a mixture of M1−M4 muscarinic receptors may be a useful way to screen and group a large number of compounds into apparent agonist, partial agonist, and antagonist classes of cholinergic agents.Keywords
This publication has 17 references indexed in Scilit:
- Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonistsBritish Journal of Pharmacology, 1995
- M3 muscarinic receptors on murine HSDM1C1 cells: Further functional, regulatory, and receptor binding studiesNeurochemical Research, 1995
- Histamine receptor‐subtype affinities, selectivities, and potencies of emedastine, a novel H1‐selective antagonist, and other ocularly employed antihistaminesDrug Development Research, 1994
- Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 bindingBritish Journal of Pharmacology, 1991
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sitesBritish Journal of Pharmacology, 1989
- Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo‐M ratio as an index of efficacy at cortical muscarinic receptorsBritish Journal of Pharmacology, 1988
- Analysis of radioligand binding experimentsJournal of Pharmacological Methods, 1985